131 related articles for article (PubMed ID: 30007243)
1. Corrigendum to "Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity" [Eur. J. Med. Chem. 138 (2017) 128-139].
Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2018 Aug; 156():302-303. PubMed ID: 30007243
[No Abstract] [Full Text] [Related]
2. Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity.
Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
Eur J Med Chem; 2017 Sep; 138():128-139. PubMed ID: 28666191
[TBL] [Abstract][Full Text] [Related]
3. Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly.
Massari S; Nannetti G; Goracci L; Sancineto L; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Facchini M; Palù G; Cruciani G; Loregian A; Tabarrini O
J Med Chem; 2013 Dec; 56(24):10118-31. PubMed ID: 24313730
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action" [Eur. J. Med. Chem. 204 (2020) 112481].
Tran QTN; Tan DWS; Wong WSF; Chai CLL
Eur J Med Chem; 2021 Jan; 209():112943. PubMed ID: 33097302
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents" [Eur. J. Med. Chem. 162 (162) (2019) 203-211].
Su L; Li J; Zhou Z; Huang D; Zhang Y; Pei H; Guo W; Wu H; Wang X; Liu M; Yang CG; Chen Y
Eur J Med Chem; 2019 Apr; 168():385. PubMed ID: 30826513
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates" [Eur. J. Med. Chem. 134(2017) 133-139].
Tian Z; Si L; Meng K; Zhou X; Zhang Y; Zhou D; Xiao S
Eur J Med Chem; 2021 Nov; 223():113647. PubMed ID: 34153573
[No Abstract] [Full Text] [Related]
7. Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].
Ojha R; Nepali K; Chen CH; Chuang KH; Wu TY; Lin TE; Hsu KC; Chao MW; Lai MJ; Lin MH; Huang HL; Chang CD; Pan SL; Chen MC; Liou JP
Eur J Med Chem; 2020 Sep; 201():112404. PubMed ID: 32526554
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening" [Eur. J. Med. Chem. 179 (2019) 634-648].
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2020 Mar; 190():112130. PubMed ID: 32074493
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308].
Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2020 Aug; 200():112464. PubMed ID: 32512484
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Design and synthesis of novel artemisinin hybrids with potent activities against human colorectal cancer cells in vitro and in vivo" [Eur. J. Med. Chem. 182 (2019) 111665].
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2020 May; 194():112256. PubMed ID: 32220686
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5" [Eur. J. Med. Chem. 238 (2022) 114446].
Fang Z; Mu B; Liu Y; Guo N; Xiong L; Guo Y; Xia A; Zhang R; Zhang H; Yao R; Fan Y; Li L; Yang S; Xiang R
Eur J Med Chem; 2023 Jul; 255():115368. PubMed ID: 37119665
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].
Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
Eur J Med Chem; 2018 Aug; 156():628-630. PubMed ID: 30031973
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
Chen KF; Tai WT; Hsu CY; Huang JW; Liu CY; Chen PJ; Kim I; Shiau CW
Eur J Med Chem; 2018 Jan; 143():2015. PubMed ID: 29113744
[No Abstract] [Full Text] [Related]
14. Corrigendum to "6-Amino-2,4,5-trimethylpyridin-3-ols: A new general synthetic route and antiangiogenic activity" [Eur. J. Med. Chem. 74 (2014) 126-139].
Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
Eur J Med Chem; 2017 Dec; 141():734-735. PubMed ID: 28988929
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives" [Eur. J. Med. Chem. 143 (2018) 1396-1405].
Li ZH; Zhao TQ; Liu XQ; Zhao B; Wang C; Geng PF; Cao YQ; Fu DJ; Jiang LP; Yu B; Liu HM
Eur J Med Chem; 2019 Nov; 181():111387. PubMed ID: 31376565
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Design, synthesis, DFT study and antifungal activity of the derivatives of pyrazolecarboxamide containing thiazole or oxazole ring" [Eur. J. Med. Chem. 149 (2018) 170-181].
Yan Z; Liu A; Huang M; Liu M; Pei H; Huang L; Yi H; Liu W; Hu A
Eur J Med Chem; 2018 May; 152():392. PubMed ID: 29747120
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Optimization of physicochemical properties for 4-Anilinoquinazoline inhibitors of trypanosome proliferation" [Eur. J. Med. Chem. 141 (2017) 446-459].
Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
Eur J Med Chem; 2018 May; 152():515. PubMed ID: 29754075
[No Abstract] [Full Text] [Related]
18. Corrigendum to 'Dihydroorotate dehydrogenase: A drug target for the development of antimalarials' [Eur. J. Med. Chem. 125 (2017) 640-651].
Singh A; Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2017 Mar; 128():346-347. PubMed ID: 28241929
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells" [Eur. J. Med. Chem. 123 (2016) 317-331].
Mendes VIS; Bartholomeusz GA; Ayres M; Gandhi V; Salvador JAR
Eur J Med Chem; 2016 Nov; 124():1004-1005. PubMed ID: 27783971
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives" [Eur. J. Med. Chem. 92 (2015) 332-341].
Balaji B; Balakrishnan B; Perumalla S; Karande AA; Chakravarty AR
Eur J Med Chem; 2019 Aug; 175():1. PubMed ID: 31055148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
